Bill
HB 5427
Illinois now requires licensing and strict oversight for virtual wholesale distributors to tighten the drug supply chain and ensure compliant, verifiable distribution.
HB5427 (104th General Assembly, Illinois) – Wholesale Drug Distribution Licensing Act
Overview
- Purpose: Establish and tighten licensure, regulatory oversight, and operational controls for wholesale drug distributors, including a new category: virtual wholesale distributors. Strengthens safeguards against unlicensed distribution and ties compliance to federal guidelines.
- Effective date: Immediate upon law passage.
- Key novelty: Creates explicit licensing for “virtual wholesale distributors” and imposes concrete requirements on entities that contract with such distributors.
Main purpose and intent
- Modernize Illinois’ wholesale drug distribution framework to close gaps related to virtual drug distribution and third-party logistics.
- Ensure all parties involved in the distribution chain, including entities that take title but do not take physical possession (virtual wholesalers), are properly licensed and audited.
- Align state rules with FDA guidelines and Drug Quality & Security Act principles, emphasizing secure, verifiable pedigrees and controlled distribution pathways.
Key provisions and changes
- Definitions expanded:
- Virtual wholesale distributor defined; subject to licensing when engaged in virtual drug distribution.
- Clarifies terms like “pedigree,” “authorized distributor of record,” “normal distribution channel,” “third-party logistics provider,” and other actors in the supply chain.
- Sets distinctions between wholesale distributors, virtual wholesale distributors, chain pharmacy warehouses, and other players.
- Virtual wholesale distributor licensing (new Section 25.7):
- Mandatory licensure by the Department of Financial and Professional Regulation (DFPR) for entities engaging in virtual distribution.
- Limits contracts with entities that take physical possession to shipments into Illinois.
- Required license specifics: ownership structure, contact information, facilities, insurance, and third-party logistics provider details.
- Obligates virtual wholesalers to ensure licensed partners comply with distribution rules, with emphasis on storage, security, and adherence to federal Drug Quality and Security Act provisions.
- Prohibits operating from a residential address.
- License discipline and enforcement:
- Unlicensed practice: Civil penalties up to $10,000 per offense; Department investigation authority.
- Licensure expiration, renewal, and restoration rules clarified; continued operation on expired status is unlawful.
- Temporary suspension provisions and formal hearing timelines.
- Inspection and records:
- Expanded pharmacy investigator inspection rights; broad access to premises.
- Records may be stored electronically at a central location but must be readily available for inspection within two business days.
- Transaction and pedigree rules:
- Pedigree requirements retained for tracing drug distribution; returns and exchanges follow specified channels.
- Manufacturer-level controls: verification of recipients and ensuring proper licensing status before distributing drugs.
- Shortage drugs (Section 200):
- Requires licensing for entities handling drugs listed as shortages.
- Prohibits unlicensed purchases from unlicensed sources; creates a centralized license database for verification.
- Establishes reporting mechanisms for suspected violations and directs enforcement actions; permits permissible hospital exchanges during emergencies.
- Home rule and regulatory scope:
- Home rule preemption confirmed for licensing and regulation of wholesale drug distribution activities.
Who is affected
- Wholesale drug distributors, virtual wholesale distributors, third-party logistics providers, and their affiliated entities operating in Illinois.
- Manufacturers and authorized distributors of record must align with state requirements, including pedigrees and validations.
- Hospitals, chain pharmacies, and pharmacies engaged in wholesale distribution or returns.
Procedural and timeline aspects
- Act’s provisions emphasize licensing, annual/renewal processes, and compliance inspections.
- Violations trigger penalties, injunctions, and potential license denial or revocation; temporary suspensions may occur with expedited hearings.
- Section 25.7 outlines detailed licensure application information to be submitted by virtual wholesalers.
Overall impact
- Strengthens Illinois’ regulatory oversight of the drug distribution chain, with a particular focus on virtual distribution models and the integrity of the supply chain.
- Aims to reduce counterfeit or adulterated drugs by enhancing verification, recordkeeping, and accountability across all licensed distributors.
- Creates a centralized framework that aligns state practice with federal guidelines, improving inter-state and intrastate compliance.
Compiled from official sources — confirm details with the bill’s official record.
Sign in to ask a question.
